Independent Director · Merck & Co., Inc. (MRK)

Chair, Research Committee

Paul B. Rothman, M.D director compensation at Merck (FY2025): $405K

Fiscal year 2025 director compensation for Paul B. Rothman, M.D at Merck & Co., Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 8, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Paul B. Rothman, M.D’s full pay file as a PDF — free

More than this page: up to 10 years of Paul’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Paul B. Rothman, M.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Merck Director Compensation Table · all 4 fiscal years held
In US dollars, as Merck reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$155,000——$250,000$405,000
FY2024$153,750$0$0$260,000$413,750
FY2023$150,000$0$0$230,000$380,000
FY2022$150,000$0$0$275,000$425,000

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Merck & Co., Inc. DEF 14A filed April 8, 2026, accession 0001193125-26-147704, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Merck & Co., Inc. filed document, accession 0001193125-26-147704. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2026.

Get the Merck Board Governance Report

$405,000 Paul B. Rothman, M.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 8, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Merck pays directors a $120,000 cash retainer and $220,000 in Deferred Stock Units (phantom shares).

Committees

FY2025 · as the proxy prints them

Audit · Research (Chair)

The rest of the Merck board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Christine E. Seidman, M.DIndependent Director$385,000
Douglas M. Baker JrIndependent Director$350,000
Inge G. ThulinIndependent Director$340,000
Kathy J. WardenIndependent Director$340,000
Mary Ellen CoeIndependent Director$340,000
Pamela J. CraigIndependent Director$405,000
Patricia F. RussoIndependent Director$365,000
Risa J. Lavizzo-Mourey, M.DIndependent Director$340,000
Robert M. DavisChair of the Board—
Stephen L. Mayo, Ph.DIndependent Director$350,000
Surendralal L. KarsanbhaiIndependent Director$405,000
Thomas H. GlocerLead Independent Director$415,000

The full Merck compensation record

free company brief

This page is one director within Merck's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Merck proxy · each links to its own free brief

Order MRK

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report